|
Market Closed -
Nasdaq Stockholm
19:00:00 22/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.9980 SEK | -1.19% |
|
+3.21% | +8.01% |
| 08-20 | Intervacc AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | Calendar Thursday, August 20 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 35M | - | ||||
| 74.33B | |||||
| 62.26B | |||||
| 27.72B | |||||
| 26.42B | - | ||||
| 24.62B | - |
- Stock Market
- Stocks
- IVACC Stock
- Charts Intervacc AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
